Ref. PDI/BK-BS-056/2018 8th August 2018 Re: Management Discussion and Analysis (MD&A) For the 2Q 2018 and 1H 2018 To: President The Stock Exchange of Thailand Due to depletion of Mae Sod Mine’s
Ref. PDI/BK-BS-076/2018 7th November 2018 Re: Management Discussion and Analysis (MD&A) For the three-month and nine-month periods ended September 30, 2018 To: President The Stock Exchange of
, 2019 Subject Explanation and analysis of Management for second quarter 2019 Attention Directors and manager The Stock Exchange of Thailand Inter pharma Public Company Limited (“the Company”) would like
Analysis for the year 2019 (Ending December 31, 2019) (Revise Template) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on
นาสูความเปนเลิศ ทั้งในดานพาณิชยและคุณภาพผลิตภัณฑอยางเปนมืออาชพี” May 15, 2020 Subject: Clarification on the cause of changes in operating results. To: Director and Manager The Stock Exchange of
www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
(Ending September 30, 2019) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial for Q3
. Attention: President Stock Exchange of Thailand Demeter Corporation Public Company Limited (“DCORP”) (“The Company”) would like to submit the reviewed financial statements for the first nine-month of the year
Stock Exchange of Thailand AAPICO Hitech Public Company Limited (“the Company”) would like to explain the consolidated financial statements of the Company for the 2nd quarter of fiscal year 2024 ended as
President The Stock Exchange of Thailand AAPICO Hitech Public Company Limited (“the Company”) would like to explain the consolidated financial statements of the Company for the 3rd quarter of fiscal year 2024